Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Chubb
Argus Health
Accenture
Teva

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 9,855,302

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,855,302
Title:Treatment of cancer by manipulation of commensal microflora
Abstract: Provided herein are methods of treatment and/or prevention of cancer by manipulation of commensal microflora. In particular, the amount, identity, presence, and/or ratio of microflora (e.g., gut microflora) in a subject is manipulated to facilitate one or more co-treatments.
Inventor(s): Gajewski; Thomas F. (Chicago, IL), Sivan; Ayelet (Chicago, IL), Corrales; Leticia (Chicago, IL)
Assignee: The University of Chicago (Chicago, IL)
Application Number:15/170,284
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,855,302
Patent Claims:see list of patent claims

Details for Patent 9,855,302

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23   Try a Free Trial The University of Chicago (Chicago, IL) 2035-06-01 RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04   Try a Free Trial The University of Chicago (Chicago, IL) 2035-06-01 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04   Try a Free Trial The University of Chicago (Chicago, IL) 2035-06-01 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Merck
Teva
UBS
Citi
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.